Tacrolimus 0.1% In Pseudocatalase
Product Images NDC 72934-2174

3 FDA label images from Sincerus Florida, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tacrolimus 0.1% In Pseudocatalase (NDC 72934-2174). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

D (2174 2 End)

D (2174 2 End)
Label on a white plastic container for TACROLIMUS 0.1% IN PSEUDOCATALASE by Sincerus Florida, LLC. The visible text provides directions for use, advises washing hands after application, and includes manufacturer contact information with an address in Pompano Beach, FL. The label also references the FDA and warns that the product is for external use only.*
FDA Label Image

S (2174 2 Front)

S (2174 2 Front)
Packaging label of TACROLIMUS MONOHYDRATE USP 0.1% cream in a 30 gm container. The label shows the NDC 72934-2174-2 and indicates the product is a compounded drug made in the USA. The labeler is Sincerus Florida, LLC, shown with a blue and orange logo on the label.*
FDA Label Image

D (2174 2 Middle)

D (2174 2 Middle)
The image shows a white container label for TACROLIMUS 0.1% IN PSEUDOCATALASE cream. The label lists active and inactive ingredients including Tacrolimus Monohydrate USP (0.1%) and others like Calcium Chloride, Manganese Chloride, Purified Water, and Sodium Bicarbonate with specific percentages. It includes manufacturing (01/01/1970) and lot information along with a warning about safety and use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.